MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Mar 22

PMID 32197340

Citations 5

Authors

Przemyslaw J Kotyla

Md Asiful Islam

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are single-stranded, endogenous RNA molecules that play a significant role in the regulation of gene expression as well as cell development, differentiation, and function. Recent data suggest that these small molecules are responsible for the regulation of immune responses. Therefore, they may act as potent modulators of the immune system and play an important role in the development of several autoimmune diseases. Antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by venous and/or arterial thromboses and/or recurrent fetal losses in the presence of antiphospholipid antibodies (aPLs). Several lines of evidence suggest that like other autoimmune disorders, miRNAs are deeply involved in the pathogenesis of APS, interacting with the function of innate and adaptive immune responses. In this review, we characterize miRNAs in the light of having a functional role in the immune system and autoimmune responses focusing on APS. In addition, we also discuss miRNAs as potential biomarkers and target molecules in treating APS.

Citing Articles

Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation.

Richter P, Badescu M, Rezus C, Ouatu A, Dima N, Popescu D Int J Mol Sci. 2024; 25(20).

PMID: 39457063 PMC: 11509045. DOI: 10.3390/ijms252011281.

Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS).

Sole C, Royo M, Sandoval S, Moline T, Cortes-Hernandez J Int J Mol Sci. 2023; 24(14).

PMID: 37511365 PMC: 10380201. DOI: 10.3390/ijms241411607.

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.

DIppolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G, Di Simone N Int J Mol Sci. 2023; 24(4).

PMID: 36834614 PMC: 9966557. DOI: 10.3390/ijms24043195.

Enzyme-Assisted Nucleic Acid Amplification in Molecular Diagnosis: A Review.

Wang M, Liu H, Ren J, Huang Y, Deng Y, Liu Y Biosensors (Basel). 2023; 13(2).

PMID: 36831926 PMC: 9953907. DOI: 10.3390/bios13020160.

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

Carre J, Jourdi G, Gendron N, Helley D, Gaussem P, Darnige L Int J Mol Sci. 2022; 23(1).

PMID: 35008518 PMC: 8744910. DOI: 10.3390/ijms23010093.

References

Pauley K, Cha S, Chan E . MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun. 2009; 32(3-4):189-94. PMC: 2717629. DOI: 10.1016/j.jaut.2009.02.012. View

Zhang Y, Xie B, Sun L, Chen W, Jiang S, Liu W . Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145. J Cell Mol Med. 2016; 20(6):1049-61. PMC: 4882986. DOI: 10.1111/jcmm.12825. View

Islam M, Khandker S, Alam F, Kamal M, Gan S . Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses. Autoimmun Rev. 2018; 17(3):226-243. DOI: 10.1016/j.autrev.2017.10.014. View

Evangelatos G, Fragoulis G, Koulouri V, Lambrou G . MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmun Rev. 2019; 18(11):102391. DOI: 10.1016/j.autrev.2019.102391. View

Lim L, Lau N, Garrett-Engele P, Grimson A, Schelter J, Castle J . Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-73. DOI: 10.1038/nature03315. View

Xiao C, Calado D, Galler G, Thai T, Patterson H, Wang J . MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007; 131(1):146-59. DOI: 10.1016/j.cell.2007.07.021. View

Perez-Andreu V, Teruel R, Corral J, Roldan V, Garcia-Barbera N, Salloum-Asfar S . miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle. Mol Med. 2012; 18:1466-72. PMC: 3563709. DOI: 10.2119/molmed.2012.00062. View

Vinuesa C, Rigby R, Yu D . Logic and extent of miRNA-mediated control of autoimmune gene expression. Int Rev Immunol. 2009; 28(3-4):112-38. DOI: 10.1080/08830180902934909. View

Yu J, Cao X, Zheng Y, Yan L, Wang J . Abnormal expression of miR‑133a in patients with acute myocardial infarction following radical surgery for gastric cancer and the underlying mechanism. Mol Med Rep. 2018; 18(6):5023-5029. PMC: 6236279. DOI: 10.3892/mmr.2018.9541. View

10.

Li Y, Yan L, Zhang W, Hu N, Chen W, Wang H . Suppression of endothelial nitric oxide synthase expression and endothelial cell proliferation by an intronic 27-ntmiRNA and it's a novel link to AP-1. Am J Transl Res. 2015; 7(2):285-97. PMC: 4399092. View

11.

Lu L, Boldin M, Chaudhry A, Lin L, Taganov K, Hanada T . Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010; 142(6):914-29. PMC: 3049116. DOI: 10.1016/j.cell.2010.08.012. View

12.

Lee Y, Jeon K, Lee J, Kim S, Kim V . MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002; 21(17):4663-70. PMC: 126204. DOI: 10.1093/emboj/cdf476. View

13.

Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel D . TRAF6 is a signal transducer for interleukin-1. Nature. 1996; 383(6599):443-6. DOI: 10.1038/383443a0. View

14.

Li N, Sun J, Yu L . Evaluation of the circulating MicroRNA-495 and Stat3 as prognostic and predictive biomarkers for lower extremity deep venous thrombosis. J Cell Biochem. 2017; 119(7):5262-5273. DOI: 10.1002/jcb.26633. View

15.

Perez-Sanchez C, Aguirre M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Arias de la Rosa I . 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'. Sci Rep. 2016; 6:31375. PMC: 4977549. DOI: 10.1038/srep31375. View

16.

Le X, Yu X, Shen N . Novel insights of microRNAs in the development of systemic lupus erythematosus. Curr Opin Rheumatol. 2017; 29(5):450-457. DOI: 10.1097/BOR.0000000000000420. View

17.

Reverter J, Tassies D, Font J, Monteagudo J, Escolar G, Ingelmo M . Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s. Arterioscler Thromb Vasc Biol. 1996; 16(11):1319-26. DOI: 10.1161/01.atv.16.11.1319. View

18.

Bao C, Zhang D, Wang N, Zhu X, Zhao Q, Sun X . MicroRNA-335-5p suppresses lower extremity deep venous thrombosis by targeted inhibition of PAI-1 via the TLR4 signalingpathway. J Cell Biochem. 2017; 119(6):4692-4710. DOI: 10.1002/jcb.26647. View

19.

Ray M, Gabunia K, Vrakas C, Herman A, Kako F, Kelemen S . Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in × Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R). Arterioscler Thromb Vasc Biol. 2018; 38(6):1297-1308. PMC: 5970062. DOI: 10.1161/ATVBAHA.118.310929. View

20.

Duan W, Zhang W, Jia J, Lu Q, Gershwin M . Exosomal microRNA in autoimmunity. Cell Mol Immunol. 2019; 16(12):932-934. PMC: 6884449. DOI: 10.1038/s41423-019-0319-9. View